Login

Journal Front Page

News & Events

  • Call for article for July 2025 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 June, 2025 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • April 2025 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 14, Issue 2 (April 2025 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

FORMULATION & EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF SIMVASTATIN USING SYNTHETIC POLYMERS

Triveni Barange*, Praveen Tahilani, Jitendra Banweer

Sagar Institute of Research Technology & Science-Pharmacy, Bhopal (M.P.) 462041

ABSTRACT

In the present research to formulate sustained release matrix tablet of simvastatin. This study examined the release of Simvastatin from polymer matrices PVP K-30 and PEG 4000 separately. Simvastatin is a antihyperlipidemic drug and short half life (t1/2) and usually oral dose regimen (5 to 40 mg) taken to 4 times a day. Sistained release matrix tablet of simvastatin were prepared using PEG 4000, PVP K-30 and microcrystalline cellulose by using by direct compression technique. The tablets were evaluated for physical parameters like thickness, hardness, friability, weight variation, and in vitro release studies. The maximum drug release was found to be 98.59 % over a period of 24 hours in PEG 4000 based tablets as compare to PEG 4000 and PVP K-30. All the formulations were stored at 450±20C, 75 ± 5% RH and subjected to stability studies up to 45 days. It showed that all the formulations are physically and chemically stable.

Keywords: Sustained release, Simvastatin, Direct compression Technique.


[Full Text Article]